Related by context. All words. (Click for frequent words.) 73 cognitive decline 68 cognitive function 68 mild cognitive impairment 68 cognitive deficits 67 dementia 67 cognitive dysfunction 66 depressive symptoms 66 mild cognitive 65 cognitive impairments 64 subclinical hypothyroidism 64 parkinsonism 63 impaired cognition 63 cognitive functioning 63 brain atrophy 63 cognitively normal 62 cognitive 62 subclinical atherosclerosis 62 white matter hyperintensities 62 microalbuminuria 61 Alzheimer disease 61 proliferative diabetic retinopathy 61 MMSE scores 61 brain shrinkage 61 subclinical hyperthyroidism 60 metabolic syndrome 60 neurological abnormalities 60 autonomic dysfunction 60 cognition 60 neurocognitive 60 neuropsychological deficits 59 NAFLD 59 psychosocial functioning 59 hippocampal volume 59 psychotic symptoms 59 sleep disturbances 59 cognitively intact 59 SRBD 59 somatic symptoms 59 neurocognitive deficits 59 vascular dementia 59 neurocognitive impairment 59 androgen deficiency 59 neurological impairment 58 Alzheimers disease 58 Alzheimer pathology 58 prehypertension 58 neurodevelopmental 58 albuminuria 58 amyloid pathology 58 neurologic 58 T1DM 58 juvenile idiopathic arthritis 58 retinopathy 58 colorectal adenomas 58 amnestic MCI 58 idiopathic Parkinson disease 58 Mild Cognitive Impairment 58 FTLD 58 elevated homocysteine 58 hypothyroidism 58 neurocognitive function 58 coronary calcification 58 extrapyramidal symptoms 58 perimenopausal women 58 generalized epilepsy 58 cognitive functions 58 glucose intolerance 57 cognitively impaired 57 disease progression 57 APOE e4 57 kidney function 57 overt nephropathy 57 OSAHS 57 cardiovascular mortality 57 vestibular dysfunction 57 cognitive abilities 57 urate levels 57 autistic traits 57 insulin resistance 57 hypoglycemic episodes 57 optic neuritis 57 LUTS 57 metabolic abnormalities 57 comorbidities 57 MetS 57 habitual snoring 57 daytime sleepiness 57 poststroke 57 endothelial dysfunction 57 proliferative retinopathy 57 depressive symptomatology 57 asymptomatic PAD 57 carotid IMT 57 amnestic mild cognitive impairment 57 diabetic retinopathy 57 uric acid levels 57 thyroid dysfunction 57 LRRK2 mutations 57 generalized seizures 57 dopaminergic therapy 57 mood disorders 57 proteinuria 57 postoperative delirium 56 affective psychoses 56 Cognitive impairment 56 impaired fasting glucose 56 brain lesions 56 psychiatric comorbidities 56 microbleeds 56 dementias 56 syncope 56 Sjögren syndrome 56 onset seizures 56 serum folate 56 ischemic stroke 56 androgen depletion 56 nondemented 56 axonal damage 56 knee OA 56 untreated sleep apnea 56 comorbid disorders 56 premorbid 56 Parkinson disease PD 56 vitamin B# deficiency 56 subsyndromal 56 Mild cognitive impairment 56 neuropathological 56 reflux symptoms 56 Excessive daytime sleepiness 56 impaired glucose tolerance 56 cardiorespiratory fitness 56 comorbid anxiety 56 ADHD symptoms 56 neurologic disorder 56 thyrotropin levels 56 fasting glucose levels 56 skeletal fluorosis 56 RLS symptoms 56 hypertension 56 epilepsy 56 renal dysfunction 56 daytime drowsiness 56 diabetes mellitus 56 olfactory dysfunction 56 liver fibrosis 56 cataract formation 56 abnormalities 56 narcolepsy cataplexy 56 metabolic acidosis 55 cardiovascular disease 55 GH deficiency 55 Depressive symptoms 55 glucose tolerance 55 hemiparesis 55 neurodevelopmental outcome 55 benign breast 55 neurocognitive functioning 55 tic disorder 55 tau pathology 55 psychiatric comorbidity 55 synaptic function 55 affective disorder 55 Korsakoff syndrome 55 urinary symptoms 55 diabetes mellitus DM 55 hippocampal atrophy 55 neurodevelopmental impairment 55 T2DM 55 coronary artery calcium 55 neuropsychological impairments 55 GBA mutations 55 migraineurs 55 obstructive sleep apnea 55 cerebral infarction 55 major depressive disorder 55 psychiatric disorders 55 severe hypoglycemia 55 subclinical 55 vasomotor symptoms 55 HNSCC 55 visual impairment 55 neurocognitive impairments 55 cardiac dysfunction 55 frontotemporal dementia 55 neuropsychiatric symptoms 55 glaucoma 55 POAG 55 serum phosphate 55 AAT deficiency 55 comorbidity 55 APOE4 55 alexithymia 55 neuropsychological 55 hepatic steatosis 55 Obstructive sleep apnea 55 serum folate concentrations 55 elevated depressive symptoms 55 neurodevelopmental outcomes 55 uncontrolled epilepsy 55 knee osteoarthritis 55 Sleep disordered breathing 55 Alzheimer disease AD 55 gene variant 55 uncontrolled seizures 55 MMSE score 55 myocardial ischemia 54 microvascular disease 54 arterial thickening 54 psychiatric morbidity 54 testosterone supplementation 54 PsA 54 sporadic ALS 54 elevated ALT 54 Mental retardation 54 neurological degeneration 54 neurologic dysfunction 54 symptom severity 54 elevated CRP 54 neuropsychological functioning 54 schizophrenia 54 postoperative AF 54 psychotic disorders 54 neurological 54 hippocampal function 54 psychological distress 54 neurological impairments 54 coronary artery calcification 54 impaired renal 54 B# deficiency 54 microvascular complications 54 Alzheimer Disease AD 54 comorbid conditions 54 penetrance 54 atherosclerotic disease 54 clinically meaningful improvements 54 psychosocial variables 54 decrements 54 progressive neurodegenerative disorder 54 APOE gene 54 alcoholic cirrhosis 54 untreated psychosis 54 psychotic illness 54 ASDs 54 APOE genotype 54 lung function 54 Hashimoto thyroiditis 54 sarcopenia 54 left ventricular dysfunction 54 renal impairment 54 carotid stenosis 54 osteopenia 54 underlying pathophysiology 54 atherosclerosis 54 neurologic symptoms 54 elevated serum creatinine 54 prediabetes 54 adrenal function 54 suicidality 54 peripheral neuropathy 54 prolactin levels 54 subcortical 54 schizophrenia CIAS 54 #q# deletion syndrome 54 folate deficiency 54 hepatic fibrosis 54 claudication 54 gallstone disease 54 hypopituitarism 54 carotid atherosclerosis 54 nerve degeneration 54 primary biliary cirrhosis 54 donepezil 54 hypersomnia 54 sensorineural hearing loss 54 cerebral atrophy 54 psychotic illnesses 54 thyroid function 54 comorbid depression 54 myopia nearsightedness 54 cortical thinning 54 recurrent VTE 54 bronchopulmonary dysplasia 54 serum cholesterol 54 colorectal adenoma 54 neuropathy 54 elevated triglyceride levels 54 nondepressed 54 disease NAFLD 54 serum vitamin D 54 sensory disturbances 54 nonalcoholic steatohepatitis NASH 54 gait disturbance 54 mIU L 54 hippocampal volumes 54 macroalbuminuria 53 amyloid deposition 53 onset Alzheimer disease 53 euthymic patients 53 Prehypertension 53 developmental delays 53 HPA axis 53 metabolic dysfunction 53 mild cognitive impairments 53 airflow obstruction 53 behavioral abnormalities 53 multi infarct dementia 53 Klinefelter syndrome 53 Anxiety disorders 53 unprovoked seizures 53 abdominal adiposity 53 hyperglycemia 53 hypercalciuria 53 unmeasured factors 53 syndrome OSAS 53 nonischemic 53 ADAS Cog 53 dysthymia 53 dietary calcium intake 53 amenorrhea 53 chronic renal insufficiency 53 geographic atrophy 53 dyskinesia 53 systolic hypertension 53 Wernicke Korsakoff syndrome 53 hereditary predisposition 53 transaminase levels 53 Diabetic neuropathy 53 overactivity 53 nonadherence 53 prodrome 53 neurodevelopmental disorder 53 Alzheimer disease vascular dementia 53 abnormal lipid 53 APOE ε4 53 generalized tonic clonic seizures 53 metabolic syndrome MetS 53 LQTS 53 neurodegenerative disease 53 coronary disease 53 mitochondrial dysfunction 53 albumin excretion 53 neurologic sequelae 53 blood Phe levels 53 primary generalized tonic 53 untreated obstructive sleep 53 neuropsychiatric disorder 53 Sarcopenia 53 neovascular 53 neurosensory 53 affective psychosis 53 ApoE4 53 spastic diplegia 53 HbA1c levels 53 hypoglycemia 53 coronary artery disease 53 pernicious anemia 53 primary aldosteronism 53 antihypertensive therapy 53 vascular cognitive impairment 53 affective disorders 53 fragility fractures 53 aMCI 53 non affective psychosis 53 hematopoietic cancers 53 da mage 53 premenopausal 53 arterial stiffness 53 AUDs 53 dysthymic disorder 53 abstinent alcoholics 53 ADPKD 53 nonfasting triglycerides 53 neuromotor 53 comorbid 53 relapsing remitting 53 kidney dysfunction 53 levodopa therapy 53 physiological arousal 53 primary ovarian insufficiency 53 prostate carcinogenesis 53 drusen 53 HRQOL 53 glucose metabolism 53 cognitive domains 53 juvenile idiopathic arthritis JIA 53 HbA 1c 53 cirrhotic 53 senile dementia 53 detrusor overactivity 53 cortisol secretion 53 neurodegeneration 53 prostate cancer CaP 53 Major Depressive Disorder 53 progressive neurologic 53 atrophic gastritis 53 bone density 53 recurrent stroke 53 pulmonary hypertension PH 53 acute psychosis 53 Vitamin D insufficiency 53 plasma homocysteine 53 hemiplegia 52 atypical parkinsonism 52 Genetic predisposition 52 onset diabetes mellitus 52 C reactive protein 52 elevated blood glucose 52 left ventricular hypertrophy 52 NIHSS score 52 poorer prognosis 52 attention-deficit/hyperactivity disorder ADHD 52 familial AF 52 idiopathic 52 MMSE 52 Osteopenia 52 hyperglycaemia 52 Chronic insomnia 52 neuronal dysfunction 52 fibrosis 52 choroidal neovascularization 52 aminotransferase levels 52 cystatin C 52 cardiac abnormalities 52 macrovascular disease 52 systolic dysfunction 52 diabetic kidney 52 anterior temporal 52 perimenopause 52 hirsutism 52 gestational diabetes mellitus 52 EDSS scores 52 nonalcoholic steatohepatitis 52 thyroid hormone levels 52 Genetic variants 52 left ventricular systolic 52 hyperinsulinemia 52 intractable epilepsy 52 artery stenosis 52 basal cell nevus syndrome 52 vertebral fracture 52 motor neuron degeneration 52 de ath 52 mental retardation 52 alcoholic fatty liver 52 elevated triglycerides 52 aneurysmal subarachnoid hemorrhage 52 Vitamin B# deficiency 52 colorectal neoplasia 52 intermittent claudication 52 familial adenomatous polyposis 52 post thrombotic syndrome 52 sleep disordered breathing 52 akinesia 52 Insulin resistance 52 anticholinergic medications 52 thromboembolic 52 variceal bleeding 52 advanced adenoma 52 clinically meaningful improvement 52 Longitudinal studies 52 daytime alertness 52 arterial calcification 52 preserved systolic 52 telomere length 52 ataxia 52 neurologic deficits 52 incurable neurological disorder 52 convergence insufficiency 52 artery calcification 52 anticholinergic drugs 52 sudden cardiac death 52 autism spectrum disorders 52 systemic inflammation 52 neovascular AMD 52 demyelination 52 pathologic fractures 52 untreated celiac disease 52 behavioral disturbances 52 ADHD 52 CLBP 52 intracranial hypertension 52 VaD 52 baseline HbA1c 52 renal insufficiency 52 familial ALS 52 angiotensin receptor blockers ARBs 52 inflammatory markers 52 Suicidal ideation 52 MGUS 52 rheumatic disease 52 chronic insomnia 52 growth hormone secretion 52 chronicity 52 cardio respiratory fitness 52 periprocedural MI 52 adenoma 52 serum uric acid 52 irreversible blindness 52 silent myocardial ischemia 52 valproate 52 neurological dysfunction 52 calcium supplementation 52 syndromal 52 vitamin D insufficiency 52 disc degeneration 52 asymptomatic carotid stenosis 52 androgen deprivation 52 progranulin mutations 52 left ventricular diastolic 52 choroidal neovascularization CNV 52 euthymic 52 bulimia nervosa 52 BLLs 52 osteoporotic fracture 52 hyperactivity impulsivity 52 venous thrombosis 52 prefrontal cortical 52 testicular tumors 52 neurological disorder affecting 52 fasting insulin 52 visuospatial 52 tardive dyskinesia 52 neuroleptics 52 impairment 52 polyp recurrence 52 retinitis pigmentosa RP 52 neuroimaging studies 52 amenorrhoea 52 serum sodium 52 tryptophan depletion 52 shorter telomeres 52 maintaining cardiorespiratory fitness 52 Major depressive disorder 51 cardiovascular disease CVD 51 PAOD 51 amyloid deposits 51 shorter telomere length 51 ε4 51 CNTNAP2 51 abnormal lipids 51 SHPT 51 OAB symptoms 51 cytopenias 51 nasal obstruction 51 hippocampal dysfunction 51 CP CPPS 51 impaired endothelial 51 underactive thyroid 51 serum calcium 51 coronary heart 51 neurosyphilis 51 Generalized anxiety disorder 51 biochemical abnormalities 51 tumor recurrence 51 neuropathologic 51 endothelial function 51 cirrhosis 51 PCNSL 51 hip fracture 51 dysarthria 51 congenital deficiency 51 extrapyramidal 51 normotensive 51 ventricular remodeling 51 serum testosterone 51 decompensated heart failure 51 virologic response 51 nonvertebral fracture 51 Migraine headaches 51 recurrent wheezing 51 serum PSA 51 chronic periodontitis 51 ApoE gene 51 mood dysregulation 51 clinically detectable 51 hydroxyvitamin D levels 51 adiponectin levels 51 enteroviral infection 51 ApoE4 gene 51 aldosterone 51 cerebellar 51 dermatomyositis 51 levodopa 51 EBV infection 51 HbF 51 parkinsonian symptoms 51 PTSD symptoms 51 neurodevelopmental disorders 51 synaptic plasticity 51 involuntary movements 51 open angle glaucoma 51 atopic 51 anticholinergic effects 51 serum urate levels 51 urate 51 ACh 51 fragility fracture 51 cardioembolic stroke 51 acute myelogenous leukemia AML 51 parkinsonian 51 Parkinson disease 51 knee osteoarthritis OA 51 tic severity 51 cardiac toxicity 51 psychiatric disorder 51 EXJADE 51 serum IGF 51 aminotransferases 51 posttraumatic stress disorder PTSD 51 Secondhand smoke exposure 51 IUGR 51 cortical thickness 51 apolipoprotein E4 51 Myotonic dystrophy 51 neurocognitive disorder 51 untreated OSA 51 hypotonia 51 lipid levels 51 pharmacologic treatments 51 PCa 51 undiagnosed untreated 51 prehypertensive 51 metabolic abnormality 51 psychomotor 51 CHD mortality 51 HRQoL 51 infarcts 51 unmeasured confounders 51 neurologic disorders 51 haemorrhagic stroke 51 dyskinesias 51 hypometabolism 51 Pervasive Developmental Disorder 51 PLMS 51 REM sleep behavior 51 cholinergic tone 51 VUR 51 underactive thyroids 51 cryptogenic stroke 51 bradykinesia 51 Neovascular AMD 51 plasma folate 51 arterial thromboembolic events 51 nonmelanoma skin cancers 51 chronic pancreatitis 51 interstitial cystitis 51 premenstrual syndrome PMS 51 psychosis 51 creatinine levels 51 PGTC seizures 51 hypertensives 51 sinus node dysfunction 51 galanin 51 degenerative neurological diseases 51 preserved ejection fraction 51 polycystic ovary syndrome PCOS 51 familial hypercholesterolemia 51 recurrent miscarriage 51 orthostatic hypotension 51 plasma homocysteine levels 51 clinically insignificant 51 hyperkalemia 51 akinetic mutism 51 recurrent ischemia 51 paralysis blindness 51 myelin breakdown 51 magnesium intake 51 acetabular dysplasia 51 TEAEs 51 expressive aphasia 51 overt HE 51 Vascular dementia 51 behavioral disinhibition 51 neuropsychological impairment 51 familial pancreatic cancer 51 severely cognitively impaired 51 gene variants 51 overactive bladder symptoms 51 Alzheimer 51 estrogen deficiency 51 hyperthyroidism 51 venlafaxine XR 51 autoimmune thyroiditis 51 anemia hemoglobin 51 VMAT2 51 recurrent atrial fibrillation 51 cirrhotic patients 51 typical antipsychotics 51 lipid lowering medications 51 pseudotumor cerebri 51 e4 allele 51 neurodegenerative disorder 51 serum parathyroid hormone 51 diabetic nephropathy 51 vitamin D supplementation 51 primary progressive aphasia 51 schizophrenia schizoaffective disorder 51 Calcium intake 51 liver histology 51 cryptorchidism 51 structural abnormalities 51 ARMD 51 insulin resistance syndrome 51 mild mental retardation 51 hypertension diabetes mellitus 51 oxygen desaturation 51 sequelae 51 elevated LDL cholesterol 51 autism spectrum disorder 51 metabolic disturbances 51 Alzheimers Disease 51 elevated uric acid 51 hypochondriasis 51 neuro degenerative disease 51 seizure disorders 50 dysthymic 50 depressive disorders 50 gastric carcinoma 50 inflammatory polyarthritis 50 cerebrovascular events 50 Primary IGFD 50 uncontrolled asthma 50 Severe Primary IGFD 50 KIBRA 50 isolated systolic hypertension 50 unexplained fainting 50 beta blocker therapy 50 hyperreflexia 50 coronary atherosclerosis 50 Knee osteoarthritis 50 osteopenic 50 Lennox Gastaut syndrome 50 Daytime sleepiness 50 lowest tertile 50 diabetic gastroparesis 50 vitamin D deficiency 50 PDE 5i 50 neurotoxic effects 50 BRCA mutations 50 transferrin saturation 50 esophageal adenocarcinoma 50 hypoxemia 50 carotid artery narrowing 50 obstructive apnea 50 2D 4D ratio 50 rhythm disturbances 50 neurologic impairment 50 Venous thromboembolism 50 elevated creatinine 50 idiopathic PD 50 HRQL 50 sub syndromal 50 hyponatremia 50 non aspirin NSAIDs 50 dietary glycemic index 50 symptoms 50 hypovitaminosis D 50 autoimmune thyroid 50 hyposmia 50 kidney disease 50 recurrent seizures 50 nondiabetic 50 Chronic pancreatitis 50 temporal arteritis 50 causal pathway 50 partial onset seizures 50 prediabetic 50 retinal dysfunction 50 Parkinson Disease PD 50 Critical limb ischemia 50 myoclonus 50 systemic lupus erythematosus 50 neurodevelopmental disability 50 postmenopause 50 aMCI precursor 50 serum creatinine levels 50 nonfatal MI 50 loop diuretics 50 nonfasting triglyceride levels 50 renal function 50 CVD mortality 50 homocysteine levels 50 neurocognition 50 platelet activation 50 aspirin NSAIDs 50 HeFH 50 autosomal dominant inheritance 50 dementing illness 50 comorbid psychiatric 50 afib 50 abstract reasoning 50 polyarticular 50 nicotine dependence 50 myoclonic seizures 50 schizotypal traits 50 dental fluorosis 50 musculoskeletal pain 50 #.#ng/ml 50 aspirin therapy 50 anxiety disorders 50 plasma glucose concentration 50 cardiovascular disease hypertension 50 onset Alzheimer 50 vascular dysfunction 50 irregular menstrual cycles 50 glycosylated hemoglobin HbA1c 50 relapsing remitting MS 50 telomere lengths 50 Parkinsonian Syndromes 50 pathophysiologic 50 dysregulation 50 adjunctive ABILIFY 50 EDSS score 50 elevated IOP 50 tic disorders 50 APOE e4 allele 50 suicidal ideation 50 nonvertebral fractures 50 #q#.# deletion syndrome 50 airflow limitation 50 macrovascular complications 50 impaired glucose metabolism 50 pathologic 50 exotropia 50 TT genotype 50 late onset hypogonadism 50 Asperger Disorder 50 Brugada syndrome 50 myocardial infarction MI 50 bone resorption 50 hypocalcemia 50 zinc deficiency 50 parietal cortices 50 cortical atrophy 50 CAG repeats 50 subclinical disease 50 cranial irradiation 50 paroxysmal AF 50 alzheimer disease 50 neurological disorder 50 mitochondrial function 50 renal disease 50 antidiabetic medication 50 neurodevelopment 50 diabetes insipidus 50 IgA deficiency 50 hyperhomocysteinemia 50 Alzheimer dementia 50 frontal lobe dysfunction 50 Endothelial function 50 apneas 50 reflux disease 50 adenomas 50 thyrotropin 50 sleep apnea 50 CrCl 50 juvenile myoclonic epilepsy 50 compensatory mechanisms 50 Cognitive Impairment 50 APOE allele 50 pathological gambling 50 clusterin 50 XMRV infection 50 hypothalamic pituitary adrenal axis 50 BMI z 50 heart disease 50 prognostic variables 50 gum disease 50 CSF biomarkers 50 monoclonal gammopathy 50 pharmacological therapies 50 subsyndromal depression 50 bacterial prostatitis 50 extrapyramidal symptoms EPS 50 SGPT 50 neoplasia 50 thrombotic events 50 puerperal psychosis 50 antioxidant supplementation 50 Alzheimer's 50 cognitive perceptual 50 SCr 50 delusions hallucinations 50 inherited neurological disorder 50 acute urinary retention 50 fasting glucose 50 cardiac fibrosis 50 neuroinflammatory 50 Prostatitis 50 GERD symptoms 50 intermittent exotropia 50 psychomotor skills 50 Sjogren syndrome 50 intelligence quotient IQ 50 nondrinkers 50 bone mineral 50 pharmacological interventions 50 neurofibrillary tangles 50 muscle rigidity 50 pathophysiological mechanisms 50 conventional antipsychotics 50 poststroke depression 50 immunodeficiencies 50 APOE 50 TMEM#B 50 pCR 50 T2D 50 BRCA mutation 50 elevated LDH 50 hypoglycaemic episodes 50 hematologic toxicity 50 systemic lupus erythematosus SLE 50 serum lipid levels 50 inflammatory arthritis 50 attention-deficit/hyperactivity disorder 50 dysglycemia 50 recurrent UTI 50 renal scarring 50 neuroprotective effects 50 uncontrolled hypertension 50 Alzheimer disease pathology 50 impulsivity 50 Essential tremor 50 hypopneas 50 lactic acidosis 50 fasting triglyceride levels 50 co morbidities 50 Testosterone deficiency 50 antidepressant therapy 50 emotional lability 50 thiopurine 50 bladder dysfunction 50 hyperprolactinemia 50 CLA supplementation 50 COPD 50 nocturnal hypoglycemia 50 Repeated concussions 50 NATRECOR R 50 xerostomia 50 atherogenic dyslipidemia 50 lipid abnormalities 50 serum estradiol 50 glomerular filtration 50 myocardial infarction 50 dysbindin 50 seizures comas 50 atypical hyperplasia 50 Subgroup analysis 50 intracerebral haemorrhage 50 excessive daytime sleepiness 50 glomerular filtration rate 50 hyperparathyroidism 50 unipolar depression 50 PNH patients 50 obesity insulin resistance 50 NF1 50 folate intake 50 RLS sufferers 50 preeclampsia 50 recurrent abdominal pain 50 apnea hypopnea index 50 premenopause 50 inattention hyperactivity 50 Observational studies 50 androgen deprivation therapy 50 fatty liver disease 50 diabetes 50 menopausal symptom 50 ventricular enlargement 50 neutrophil counts 50 hyperphenylalaninemia HPA due 50 vitamin D inadequacy 50 rheumatoid factor 50 myeloproliferative diseases 50 mitochondrial toxicity 50 Francine Grodstein 50 subclinical inflammation 50 hypoperfusion 50 nephropathy 50 SNHL 50 gene APOE 50 idiopathic generalized epilepsy 50 renal artery stenosis 50 akathisia 50 spinocerebellar ataxia 50 glycemia 50 osteoarthritis 50 delayed gastric emptying 50 tardive dyskinesia TD 50 rs# [002] 50 subclinical cardiovascular disease 50 chlamydial infection 49 agranulocytosis 49 diastolic dysfunction 49 macular degeneration 49 aphasia 49 Neuropsychological 49 distal colon cancer 49 coronary stenosis